BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

OncoCyte Corporation 

1301 Harbor Bay Parkway

Alameda  California  94502  U.S.A.
Phone: 510-521-3390 Fax: 510-521-3389


SEARCH JOBS


Industry
Biotechnology






 Company News
BioTime (BTX) Subsidiary OncoCyte Corporation Initiates Clinical Development Of Bladder Cancer Diagnostics In The United States And China 1/27/2014 9:32:14 AM    More...
BioTime (BTX)’s Subsidiary OncoCyte Corporation and The Wistar Institute to Collaboratively Develop Cancer Diagnostics 10/15/2013 9:53:58 AM    More...
BioTime (BTX)’s Subsidiary OncoCyte Corporation Publishes Data on the Gene FSIP1 as a Breast Cancer-Specific Marker 8/5/2013 9:38:14 AM    More...
BioTime (BTX)’s Subsidiary OncoCyte Corporation Provides an Update on the Development of the Novel Pan-Cancer Diagnostic Product PanC-DxTM 1/31/2013 10:00:08 AM    More...
BioTime (BTX) and OncoCyte Corporation Publish Data on the Gene COL10A1 as a Marker and Potential Diagnostic for a Wide Array of Human Cancers 8/16/2012 9:37:37 AM    More...
BioTime (BTX)'s Subsidiary OncoCyte Corporation Provides Update on PanC-DxTM, and Related Diagnostic Products 4/24/2012 8:42:13 AM    More...
BioTime (BTX)’s Subsidiary OncoCyte Corporation Provides an Update on the Development of the Novel Pan-Cancer Diagnostic Product PanC-DxTM 3/22/2012 6:51:09 AM    More...
ReCyte Therapeutics and OncoCyte Corporation Release: BioTime (BTX) Licenses Technology for Key Regulatory Gene Underlying Cancer and Stem Cell Reprogramming from The Wistar Institute 1/24/2012 6:55:12 AM    More...
BioTime (BTIM.PK)'s Subsidiary OncoCyte Corporation Expands Cancer Programs with $10 Million Equity Financing 8/24/2011 7:06:35 AM    More...
BioTime (BTIM.PK) Subsidiary OncoCyte Corporation Receives Second $2,000,000 Equity Tranche; BioTime Plans Additional $2,250,000 Investment 1/7/2010 8:57:35 AM    More...
12

//-->